It was from a business model perspective. They are more proactive rather than the previous and still running more reactive distributor model. Mundi are boots on the street hustling talking to doctors, networking etc. I know they expressed optimism that Mundi will do well. How well and when? Who knows.
I personally believe they will try and find others that work in this way. So many irons in the fire. The way I see it is the B Braun deal works government agencies and gets integrated to the Total Pathways product, Mundi is more face to face sales calls and education at the doctor level and with US clearance they can broaden and try both methods.
The question I asked was “let’s assume broad market clearance in the US, then what?” They loved the question and the answer is about business models and deals like Dr Scholls. Lots of avenues to go down. IMO it will be all about execution bc the possibilities are limitless even for a multi billion company. I get the sense Keith is great at executing.
My thoughts. Good luck
News 
Market Data 
Discover 
AI
